Karin A. Boomars

1.5k total citations
41 papers, 637 citations indexed

About

Karin A. Boomars is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Karin A. Boomars has authored 41 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 17 papers in Cardiology and Cardiovascular Medicine and 9 papers in Rheumatology. Recurrent topics in Karin A. Boomars's work include Pulmonary Hypertension Research and Treatments (36 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Eosinophilic Disorders and Syndromes (6 papers). Karin A. Boomars is often cited by papers focused on Pulmonary Hypertension Research and Treatments (36 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Eosinophilic Disorders and Syndromes (6 papers). Karin A. Boomars collaborates with scholars based in Netherlands, France and Germany. Karin A. Boomars's co-authors include Mirjam Kool, Thomas Koudstaal, Annemien E. van den Bosch, Pieter van Paassen, Laurie W. Geenen, Leon M. van den Toorn, Rudi W. Hendriks, Jennifer A. C. van Hulst, Jules M. van den Bosch and Sjoerd Sc. Wagenaar and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Karin A. Boomars

39 papers receiving 632 citations

Peers

Countries citing papers authored by Karin A. Boomars

Since Specialization

Citations

This map shows the geographic impact of Karin A. Boomars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin A. Boomars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin A. Boomars more than expected).

Fields of papers citing papers by Karin A. Boomars

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin A. Boomars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin A. Boomars. The network helps show where Karin A. Boomars may publish in the future.

Co-authorship network of co-authors of Karin A. Boomars

This figure shows the co-authorship network connecting the top 25 collaborators of Karin A. Boomars. A scholar is included among the top collaborators of Karin A. Boomars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin A. Boomars. Karin A. Boomars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal Treatment 2025 ·Pulmonary Circulation ·(unknown), (unknown), (unknown), Joyce Peper, Benno Rensing, J.P. van Kuijk, Barbara J.M. Mulder, Dirk van den Heuvel, Karin A. Boomars, (unknown), Johannes J. Mager, Martijn C. Post	0
2	IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension 2025 ·Journal of the American Heart Association ·(unknown), Ly Tu, (unknown), Lin Deng, (unknown), Carole Phan, Thierry van den Bosch, Karin Tran‐Lundmark, Bence Nagy, Horst Olschewski, Xiaoxuan Li, (unknown), Danan Wang, Yi Yan, Lijun Fu, Karin A. Boomars, Christophe Guignabert, Daphne Merkus	0
3	Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies 2024 ·Pulmonary Circulation ·(unknown), (unknown), (unknown), (unknown), Leon M. van den Toorn, (unknown), (unknown), Robert M. Kauling, (unknown), Annemien E. van den Bosch, Johannes J. Mager, Karin A. Boomars, Martijn C. Post	1
4	Prognostic value of tricuspid valve regurgitation in patients with pulmonary arterial hypertension and CTEPH: A longitudinal study 2024 ·IJC Heart & Vasculature ·Kevin M. Veen, Thomas Koudstaal, (unknown), Johanna J.M. Takkenberg, Karin A. Boomars, Annemien E. van den Bosch	2
5	Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation 2023 ·Diagnostics ·Judith Potjewijd, (unknown), Karin A. Boomars, (unknown), Femke de Vries, Jan Damoiseaux, Leon J. Schurgers, Pieter van Paassen	7
6	Sexual function is impaired in women and men with pulmonary hypertension 2023 ·Clinical Research in Cardiology ·(unknown), (unknown), Hester Pastoor, (unknown), Annemien E. van den Bosch, Marco C. Post, Karin A. Boomars	6
7	Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension 2022 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), (unknown), (unknown), (unknown), Esther van de Kamp, Raphaël Thuillet, Ly Tu, Christophe Guignabert, Karin A. Boomars, (unknown), Maarten M. Brandt, Daphne Merkus	26
8	Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension 2022 ·Frontiers in Immunology ·(unknown), Thomas Koudstaal, Jennifer A. C. van Hulst, Thierry P. P. van den Bosch, (unknown), Ingrid M. Bergen, (unknown), Annemien E. van den Bosch, Paul Bresser, Mirjam Kool, Jan H. von der Thüsen, Rudi W. Hendriks, Karin A. Boomars	7
9	Role of the electrocardiogram in the risk stratification of pulmonary hypertension 2022 ·Heart ·(unknown), Robert M. Kauling, Laurie W. Geenen, Jannet A. Eindhoven, Jolien W. Roos‐Hesselink, Karin A. Boomars, Annemien E. van den Bosch	11
10	Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysis 2022 ·American Heart Journal ·(unknown), (unknown), Kevin M. Veen, (unknown), (unknown), Eric Boersma, Karin A. Boomars, Marco C. Post, Annemien E. van den Bosch	14
11	Plasma markers in pulmonary hypertension subgroups correlate with patient survival 2021 ·Respiratory Research ·Thomas Koudstaal, (unknown), Jennifer A. C. van Hulst, Peter Heukels, Ingrid M. Bergen, Laurie W. Geenen, Vivan J.M. Baggen, Annemien E. van den Bosch, Leon M. van den Toorn, (unknown), Mirjam Kool, Eric Boersma, Rudi W. Hendriks, Karin A. Boomars	27
12	The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension 2021 ·Respiratory Medicine ·(unknown), (unknown), Monique Wapenaar, (unknown), Leon M. van den Toorn, Annemien E. van den Bosch, Marco C. Post, Karin A. Boomars	17
13	DNGR1-Cre–mediated Deletion of Tnfaip3 /A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in Mice 2020 ·American Journal of Respiratory Cell and Molecular Biology ·Thomas Koudstaal, Jennifer A. C. van Hulst, (unknown), (unknown), Daphne Merkus, Ingrid M. Bergen, Michiel Alexander de Raaf, Harm Jan Bogaard, Louis Boon, Geert Loo, Joachim G.J.V. Aerts, Karin A. Boomars, Mirjam Kool, Rudi W. Hendriks	19
14	Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension 2020 ·Journal of Clinical Medicine ·(unknown), Théo Klein, Laurie W. Geenen, Ly Tu, (unknown), Annemien E. van den Bosch, Yolanda B. de Rijke, Irwin Reiss, Eric Boersma, Dirk J. Duncker, Karin A. Boomars, Christophe Guignabert, Daphne Merkus	9
15	Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension 2019 ·Frontiers in Immunology ·(unknown), Karin A. Boomars, Mirjam Kool	41
16	The Effects of a 10-wk Outpatient Pulmonary Rehabilitation Program on Exercise Performance, Muscle Strength, Soluble Biomarkers, and Quality of Life in Patients With Pulmonary Hypertension 2019 ·Journal of Cardiopulmonary Rehabilitation and Prevention ·Thomas Koudstaal, Monique Wapenaar, Dirk van Ranst, (unknown), (unknown), Annemien E. van den Bosch, (unknown), Karin A. Boomars	14
17	Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands 2016 ·Netherlands Heart Journal ·Monique Wapenaar, James Twiss, (unknown), (unknown), (unknown), (unknown), Alice Heaney, Annemien E. van den Bosch, Karin A. Boomars	8
18	Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension 2013 ·Autoimmunity ·(unknown), Jan Damoiseaux, Adriaan Duijvestijn, (unknown), Karin A. Boomars, Hans‐Peter Brunner‐La Rocca, Jan Willem Cohen Tervaert, Pieter van Paassen	28
19	Predictors of long-term survival in pulmonary hypertension treated with bosentan 2011 ·The Journal of Heart and Lung Transplantation ·Paul Bresser, Jeroen C. Vis, Rolf M.F. Berger, Hubert W. Vliegen, Madelon C Vonk, Repke J. Snijder, Leon M. van den Toorn, Arie P.J. van Dijk, Karin A. Boomars, (unknown), Barbara J.M. Mulder	1
20	Primary Pulmonary Malignant Meningioma 2005 ·The Annals of Thoracic Surgery ·(unknown), Karin A. Boomars, Jules M.M. van den Bosch, (unknown), (unknown), Cornelis A. Seldenrijk	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact